Hadassah University Hospital Mount Scopus

Jerusalem 9765422

0 studies enrolling now · 9 studies all time

What they study most

Atrial Fibrillation, Cystic Fibrosis, Diabetes Mellitus, Type 2, Heart Failure, Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization

Studies at this site

• A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
• Phase 3 Alogliptin Pediatric Study — Completed
• Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria — Stopped early
• Extension Study of Ataluren (PTC124) in Cystic Fibrosis — Completed
• Study of Ataluren (PTC124™) in Cystic Fibrosis — Completed
• Study of Ataluren (PTC124) in Cystic Fibrosis — Stopped early
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction — Completed
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed